BioAge Labs Statistics

Total Valuation

BioAge Labs has a market cap or net worth of $145.91 million. The enterprise value is -$178.86 million.

Market Cap	145.91M
Enterprise Value	-178.86M

Important Dates

The last earnings date was Tuesday, May 6, 2025, before market open.

Earnings Date	May 6, 2025
Ex-Dividend Date	n/a

Share Statistics

BioAge Labs has 35.85 million shares outstanding. The number of shares has increased by 1,051.87% in one year.

Current Share Class	35.85M
Shares Outstanding	35.85M
Shares Change (YoY)	+1,051.87%
Shares Change (QoQ)	-0.45%
Owned by Insiders (%)	3.64%
Owned by Institutions (%)	44.61%
Float	23.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	54.05
Forward PS	n/a
PB Ratio	0.47
P/TBV Ratio	0.47
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.68, with a Debt / Equity ratio of 0.03.

Current Ratio	13.68
Quick Ratio	13.56
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-58.24

Financial Efficiency

Return on equity (ROE) is -30.20% and return on invested capital (ROIC) is -20.71%.

Return on Equity (ROE)	-30.20%
Return on Assets (ROA)	-19.54%
Return on Invested Capital (ROIC)	-20.71%
Return on Capital Employed (ROCE)	-25.56%
Revenue Per Employee	$22,672
Profits Per Employee	-$1.11M
Employee Count	64
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	4.04
200-Day Moving Average	n/a
Relative Strength Index (RSI)	50.99
Average Volume (20 Days)	228,664

Short Selling Information

The latest short interest is 1.80 million, so 5.02% of the outstanding shares have been sold short.

Short Interest	1.80M
Short Previous Month	1.73M
Short % of Shares Out	5.02%
Short % of Float	7.56%
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioAge Labs had revenue of $1.45 million and -$71.05 million in losses. Loss per share was -$3.69.

Revenue	1.45M
Gross Profit	-337,000
Operating Income	-81.83M
Pretax Income	-62.16M
Net Income	-71.05M
EBITDA	-81.66M
EBIT	-81.83M
Loss Per Share	-$3.69

Full Income Statement

Balance Sheet

The company has $320.52 million in cash and $10.31 million in debt, giving a net cash position of $324.77 million or $9.06 per share.

Cash & Cash Equivalents	320.52M
Total Debt	10.31M
Net Cash	324.77M
Net Cash Per Share	$9.06
Equity (Book Value)	313.17M
Book Value Per Share	8.74
Working Capital	301.08M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$53.21 million and capital expenditures -$792,000, giving a free cash flow of -$54.01 million.

Operating Cash Flow	-53.21M
Capital Expenditures	-792,000
Free Cash Flow	-54.01M
FCF Per Share	-$1.51

Full Cash Flow Statement

Margins

Gross Margin	-23.23%
Operating Margin	-5,639.35%
Pretax Margin	-4,896.28%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BioAge Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,051.87%
Shareholder Yield	-1,051.87%
Earnings Yield	-48.69%
FCF Yield	-37.01%

Analyst Forecast

The average price target for BioAge Labs is $5.67, which is 39.31% higher than the current price. The consensus rating is "Hold".

Price Target	$5.67
Price Target Difference	39.31%
Analyst Consensus	Hold
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioAge Labs has an Altman Z-Score of 7.13 and a Piotroski F-Score of 3.

Altman Z-Score	7.13
Piotroski F-Score	3